Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
ID: ALA4524055
Max Phase: Preclinical
Molecular Formula: C29H47N5O7
Molecular Weight: 577.72
Molecule Type: Unknown
Associated Items:
ID: ALA4524055
Max Phase: Preclinical
Molecular Formula: C29H47N5O7
Molecular Weight: 577.72
Molecule Type: Unknown
Associated Items:
Canonical SMILES: C=CC[C@H]1OC(=O)CCNC(=O)[C@H](C)N(C)C(=O)[C@H](C(C)C)N(C)C(=O)[C@H]([C@@H](C)CC)NC(=O)[C@@H]2CCCN2C1=O
Standard InChI: InChI=1S/C29H47N5O7/c1-9-12-21-27(38)34-16-11-13-20(34)26(37)31-23(18(5)10-2)28(39)33(8)24(17(3)4)29(40)32(7)19(6)25(36)30-15-14-22(35)41-21/h9,17-21,23-24H,1,10-16H2,2-8H3,(H,30,36)(H,31,37)/t18-,19-,20-,21+,23-,24-/m0/s1
Standard InChI Key: XIYSEKITPHTMJT-OCCJOITDSA-N
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Natural Product: Yes | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Unknown | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Molecular Weight: 577.72 | Molecular Weight (Monoisotopic): 577.3475 | AlogP: 0.85 | #Rotatable Bonds: 5 |
Polar Surface Area: 145.43 | Molecular Species: NEUTRAL | HBA: 7 | HBD: 2 |
#RO5 Violations: 1 | HBA (Lipinski): 12 | HBD (Lipinski): 2 | #RO5 Violations (Lipinski): 2 |
CX Acidic pKa: 12.52 | CX Basic pKa: | CX LogP: 0.78 | CX LogD: 0.78 |
Aromatic Rings: 0 | Heavy Atoms: 41 | QED Weighted: 0.36 | Np Likeness Score: 1.78 |
1. Cai P, Smith D, Katz B, Pearce C, Venables D, Houck D.. (1998) Destruxin-A4 chlorohydrin, a novel destruxin from fungus OS-F68576: isolation, structure determination, and biological activity as an inducer of erythropoietin., 61 (2): [PMID:9514014] [10.1021/np970475c] |
2. Chen H, Yeh SF, Ong GT, Wu SH, Sun CM, Chou CK.. (1995) The novel desmethyldestruxin B2, from Metarhizium anisopliae, that suppresses hepatitis B virus surface antigen production in human hepatoma cells., 58 (4): [PMID:7623030] [10.1021/np50118a007] |
3. Chung YM, El-Shazly M, Chuang DW, Hwang TL, Asai T, Oshima Y, Ashour ML, Wu YC, Chang FR.. (2013) Suberoylanilide hydroxamic acid, a histone deacetylase inhibitor, induces the production of anti-inflammatory cyclodepsipeptides from Beauveria felina., 76 (7): [PMID:23822585] [10.1021/np400143j] |
4. Meng LH, Liu Y, Li XM, Xu GM, Ji NY, Wang BG.. (2015) Citrifelins A and B, Citrinin Adducts with a Tetracyclic Framework from Cocultures of Marine-Derived Isolates of Penicillium citrinum and Beauveria felina., 78 (9): [PMID:26295595] [10.1021/acs.jnatprod.5b00450] |
Source(1):